-

Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of VMware, Inc. (VMW)

SAN DIEGO & PALO ALTO, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that it is investigating the officers and directors of VMware, Inc. (NYSE: VMW) for breaches of fiduciary duties, unjust enrichment, waste of corporate assets, and violations of the Securities Exchange Act of 1934. VMware provides software in the areas of hybrid cloud, multi-cloud, modern applications, networking and security, and digital workspaces.

If you suffered a loss as a result of VMware's misconduct, click here.

VMware, Inc. (VMW) Accused of Misleading Investors

One of the financial metrics VMware regularly reports is its backlog, which the Company purports is comprised of “unfulfilled purchase orders or unfulfilled executed agreements at the end of a given period.” Between March 2019 and February 2020, VMware reported hundreds of millions of dollars in backlog in a series of press releases and financial reports, each time attesting to the accuracy of the Company's financial reporting as well as its maintenance of effective internal control over financial reporting. Then, on February 27, 2020, VMware disclosed that the SEC was conducting an investigation into the Company's backlog and associated accounting and disclosures. VMware reported that it was “fully cooperating with the SEC’s investigation and is unable to predict the outcome of this matter at this time.” On this news, VMware stock fell $15.11 per share, or more than 11%, to close at $120.52 per share.

VMware, Inc. (VMW) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
LKandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against VMware settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Paysafe Limited Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Paysafe Limited (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025. Paysafe provides end-to-end payment solutions in the United States and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Pa...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: R...
Back to Newsroom